ARTCLINE

ARTCLINE‘s vision is to become the leading biotech company for immune cell based extracorporeal sepsis therapy... Currently, we are focused on the clinical trials and the further development of our ARTICE® Therapy for the treatment of bacterial sepsis... We, the founders, and the team of ARTCLINE have been successfully involved in the transfer of medical inventions from university research to industrial applications. We have an extensive network and many years of experience in the development of biopharmaceuticals and medical devices.

Also known as: ARTCLINE GmbH

Registration numbers: HRB 10591 (W)

Primary location: Rostock Germany